HSR

Entrada Therapeutics Closes Agreement with Vertex to Discover and Develop Endosomal Escape Vehicle-Therapeutics for Myotonic Dystrophy Type 1 (DM1)

Retrieved on: 
Thursday, February 9, 2023

BOSTON, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle (EEV™)-therapeutics as a new class of medicines, today announced the expiration of the waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976 and closing of the Company’s previously announced strategic collaboration and license agreement with Vertex.

Key Points: 
  • Under the terms of the agreement announced on December 8, 2022, Entrada will receive an upfront payment of $224 million, as well as an equity investment of $26 million at $16.26 per share.
  • Entrada is eligible to receive up to $485 million for the successful achievement of certain research, development, regulatory and commercial milestones, and tiered royalties on future net sales for any products that may result from this collaboration agreement.
  • The agreement includes a four-year global research collaboration whereby Entrada will continue to advance and receive payments for certain research activities related to ENTR-701, as well as additional DM1-related research activities.
  • Vertex will be responsible for global development, manufacturing and commercialization of ENTR-701 and any additional programs stemming from Entrada’s DM1 research efforts.

Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC

Retrieved on: 
Tuesday, February 7, 2023

Additionally, the Competition and Markets Authority in the United Kingdom has elected to take no action with regard to the proposed merger.

Key Points: 
  • Additionally, the Competition and Markets Authority in the United Kingdom has elected to take no action with regard to the proposed merger.
  • The proposed merger remains subject to approval by Opiant stockholders.
  • Indivior and Opiant continue to anticipate completing the Agreement in the first quarter of 2023.
  • The Opiant Board of Directors unanimously recommends that stockholders vote “FOR” the approval and adoption of the Agreement and the approval of the acquisition.

Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC

Retrieved on: 
Monday, February 6, 2023

The waiting period expired on February 2, 2023, without any action taken by the Federal Trade Commission (FTC).

Key Points: 
  • The waiting period expired on February 2, 2023, without any action taken by the Federal Trade Commission (FTC).
  • Completion of the transaction is subject to the satisfaction of the remaining customary closing conditions, including approval by Opiant stockholders and the receipt of remaining applicable regulatory approvals.
  • Indivior and Opiant continue to anticipate completing the merger agreement in the first quarter of 2023.
  • The Opiant Board of Directors unanimously recommends that stockholders vote “FOR” the approval and adoption of the Agreement and the approval of the acquisition.

FTC, DOJ Issue Fiscal Year 2021 Hart Scott Rodino Premerger Notification Report

Retrieved on: 
Friday, February 10, 2023

The report presents fiscal year 2021 data on the HSR Premerger Notification Program that alerts the agencies to transactions that may substantially lessen competition in violation of federal law.

Key Points: 
  • The report presents fiscal year 2021 data on the HSR Premerger Notification Program that alerts the agencies to transactions that may substantially lessen competition in violation of federal law.
  • The report notes that a record-breaking 3,520 transactions were reported to both antitrust agencies during fiscal year 2021, more than twice the number that were reported the year before.
  • The report also notes that the agencies issued 65 second requests in fiscal year 2021, up from 48 the year before, reflecting a significant increase in the merger workload.
  • The report includes statistical tables profiling HSR filings and investigations during fiscal year 2021.

FTC, DOJ Issue Fiscal Year 2021 Hart Scott Rodino Premerger Notification Report

Retrieved on: 
Friday, February 10, 2023

The report presents fiscal year 2021 data on the HSR Premerger Notification Program that alerts the agencies to transactions that may substantially lessen competition in violation of federal law.

Key Points: 
  • The report presents fiscal year 2021 data on the HSR Premerger Notification Program that alerts the agencies to transactions that may substantially lessen competition in violation of federal law.
  • The report notes that a record-breaking 3,520 transactions were reported to both antitrust agencies during fiscal year 2021, more than twice the number that were reported the year before.
  • The report also notes that the agencies issued 65 second requests in fiscal year 2021, up from 48 the year before, reflecting a significant increase in the merger workload.
  • The report includes statistical tables profiling HSR filings and investigations during fiscal year 2021.

Malaysia Construction Industry Databook Report 2022: Output is Expected to Reach MYR 228,680.8 Million by 2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 19, 2023

The construction industry in Malaysia is expected to grow by 7.1% to reach MYR 181,599 million in 2022.

Key Points: 
  • The construction industry in Malaysia is expected to grow by 7.1% to reach MYR 181,599 million in 2022.
  • The construction industry in Malaysia is expected to grow steadily over the next four quarters.
  • The construction output in the country is expected to reach MYR 228,680.8 million by 2026.
  • This, along with the uptick in the approval of residential projects is also expected to assist the industry growth in 2022.

Have a good plan for HSR compliance

Retrieved on: 
Saturday, February 4, 2023

It is also a reminder that every investor—companies and individuals alike—needs to have a program in place to ensure compliance with HSR filing obligations.

Key Points: 
  • It is also a reminder that every investor—companies and individuals alike—needs to have a program in place to ensure compliance with HSR filing obligations.
  • Under Rules 802.31 and 801.32, no HSR filing was required when acquiring the convertible notes, but filing was required prior to their conversion.
  • After the first failure to file, Berkshire Hathaway assured the FTC that it would institute an HSR compliance program.
  • Not all acquisitions of voting securities require an HSR filing, and buyers sometimes make mistakes in applying the HSR rules to particular combinations of buyer, seller, asset or voting security, value, location, timing, etc.

FTC Announces 2023 Update of Size of Transaction Thresholds for Premerger Notification Filings and Interlocking Directorates

Retrieved on: 
Thursday, January 26, 2023

Section 7A(a)(2) of the act requires the Commission to revise the jurisdictional thresholds annually, based on the change in gross national product.

Key Points: 
  • Section 7A(a)(2) of the act requires the Commission to revise the jurisdictional thresholds annually, based on the change in gross national product.
  • The FTC revises the filing fees annually based on the change in the U.S. consumer price index.
  • The 2023 Consolidated Appropriations Act requires the FTC to revise the HSR filing fee thresholds.
  • For the latest news and resources, follow the FTC on social media, subscribe to press releases and read our blog.

FTC Announces 2023 Update of Size of Transaction Thresholds for Premerger Notification Filings and Interlocking Directorates

Retrieved on: 
Thursday, January 26, 2023

Section 7A(a)(2) of the act requires the Commission to revise the jurisdictional thresholds annually, based on the change in gross national product.

Key Points: 
  • Section 7A(a)(2) of the act requires the Commission to revise the jurisdictional thresholds annually, based on the change in gross national product.
  • The FTC revises the filing fees annually based on the change in the U.S. consumer price index.
  • The 2023 Consolidated Appropriations Act requires the FTC to revise the HSR filing fee thresholds.
  • For the latest news and resources, follow the FTC on social media, subscribe to press releases and read our blog.